文献速递瓣膜外科

英国再次主动脉瓣置换术的危险因素与结局

Risk Factors and Outcomes of Reoperative Surgical Aortic Valve Replacement in the United Kingdom.
PubMed 文献 · Ann Thorac Surg · 2023-01-27

研究纳入2007年1月至2019年3月英国所有再次主动脉瓣手术患者,将孤立性再次主动脉瓣置换术(AVR)与倾向匹配的原发孤立性AVR队列比较,发现再次AVR住院死亡率为3.1%(94例),原发AVR为1.9%(56例),再次手术、年龄、纽约心脏协会心功能分级和慢性肾脏病与早期死亡独立相关。

要点

  • 再次AVR住院死亡率为3.1%(94例),原发AVR为1.9%(56例)。
  • 再次手术、年龄、纽约心脏协会心功能分级、慢性肾脏病与早期死亡独立相关。
  • 原发和再次AVR的死亡率在研究期间均下降。

核心结论

  • 孤立性再次AVR可在可接受的住院死亡率下实施,并提供了供替代策略比较的基准。

研究设计与样本

  • 研究纳入2007年1月至2019年3月英国所有再次主动脉瓣手术患者,将孤立性再次AVR与倾向匹配的原发孤立性AVR队列比较。
  • 研究期间英国共实施40858例原发孤立性AVR和3015例首次孤立性再次AVR。
  • 倾向匹配的再次手术组中位年龄为69.8岁(60.8-76.2),初次手术与再次手术的中位间隔为7.69年。

主要发现

  • 再次AVR总死亡率为3.1%(94例),原发AVR为1.9%(56例)。
  • 原发和再次AVR的死亡率在研究期间均下降。
  • 再次手术、年龄、纽约心脏协会心功能分级和慢性肾脏病与早期死亡独立相关。

关键数值与推荐

  • 结局指标包括住院死亡率、神经功能障碍、术后透析、深部胸骨伤口感染和住院时间。

临床怎么用

  • 孤立性再次AVR可在可接受的住院死亡率下实施,并提供了供替代策略比较的基准。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Mortality after reoperative aortic valve surgery continues to decline but remains high compared with primary isolated replacement. We sought to examine temporal trends, morbidity, and mortality among patients undergoing isolated first-time reoperative aortic valve surgery. METHODS: The study included all patients undergoing reoperative aortic valve surgery in the United Kingdom between January 2007 and March 2019. Patients undergoing isolated reoperative aortic valve replacement (AVR) were compared with a propensity matched cohort of patients undergoing isolated primary AVR. Outcomes measured included inhospital mortality, neurologic dysfunction, postoperative dialysis, deep sternal wound infections, and hospital length of stay. RESULTS: During the study period, 40,858 primary isolated AVRs and 3015 first-time isolated reoperative AVRs were carried out in the United Kingdom. In the propensity matched reoperative group, median age of participants was 69.8 years (60.8-76.2) with median duration between the initial surgery and the reoperation being 7.69 years. Overall mortality was 3.1% (94) for reoperative AVR compared with 1.9% (56) for primary AVR. Mortality of both primary and reoperative AVR declined during the study period. Reoperation, age, New York Heart Association class, and chronic kidney disease were independently associated with early mortality. CONCLUSIONS: Reoperative isolated AVR can be performed with acceptable inhospital mortality and provides a benchmark against which alternative strategies should be compared.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Narayan P, Dimagli A, Fudulu DP, et al. Risk Factors and Outcomes of Reoperative Surgical Aortic Valve Replacement in the United Kingdom. Ann Thorac Surg. 2023. PMID: 36716908. doi:10.1016/j.athoracsur.2022.12.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。